Information from the Commission - Notice to users in the European Community of controlled substances allowed for essential uses in the Community in 2000 under Council Regulation (EC) No 3093/94 on substances that deplete the ozone layer
Date: 1999-07-22
Institutions: European Commission
Subjects: chemical product, dangerous substance, import restriction, ozone

C 208/12

EN

Official Journal of the European Communities

22.7.1999

Notice to users in the European Community of controlled substances allowed for essential uses in
the Community in 2000 under Council Regulation (EC) No 3093/94 on substances that deplete the
ozone layer

(1999/C 208/08)

This notice concerns the following substances:

(cid:151) chlorofluorocarbons (CFCs) 11, 12, 113, 114 and 115,

(cid:151) other fully halogented chlorofluorocarbons,

Parties is 3 770,2 tonnes. For laboratory uses, Decision X/19 of
the Parties has authorised the production and consumption
necessary to satisfy essential
to the
exemption as
applied to the
conditions
contained in Annex II to the report of the Sixth Meeting of
the Parties (2).

laboratory uses subject
laboratory use

(cid:151) carbon tetrachloride,

(cid:151) halons,

(cid:151) 1,1,1 trichloroethane,

(cid:151) hydrobromofluorocarbons (HBFCs).

This notice is addressed to undertakings that:

1. intend to use the above substances within the Community
for the manufacture of metered dose inhalers (MDIs), and

2. intend to acquire the above substances directly from a
producer or by import into the Community for laboratory
and analytical uses.

Controlled substances for essential uses may be obtained from
production within the Community and if necessary by import
from sources outside the Community.

Users wishing to be considered by the Commission for the
award of essential use licences for the twelve-month period
from 1 January 2000 to 31 December 2000, should apply to
the Commission for an essential use licence using the form
provided in Annex I or II to this notice.

the Parties to the Montreal Protocol on
Decision IV/25 of
substances that deplete the ozone layer sets out criteria and
a procedure
for which
for determining (cid:145)essential uses(cid:146),
continued production and consumption would be allowed
after phase-out.

In accordance with Decision IV/25 of
the Parties to the
Montreal Protocol, Articles 3 and 4 of Council Regulation
(EC) No 3093/94 of 15 December 1994 (1) on substances
that deplete the ozone layer require the determination of any
essential uses of
the abovementioned controlled substances
which may be permitted in the Community in 2000.

Decision X/6 of the Parties to the Montreal Protocol authorised
the levels of production and consumption necessary to satisfy
essential uses of CFCs for metered dose inhalers (MDIs) for the
treatment of asthma, chronic obstructive pulmonary diseases
and CFC 113 for the coating of cardiovascular surgical material.
For the production of MDIs in the European Community in
2000, the quantiy of CFCs 11, 12, 113 and 114 authrised by the

In accordance with Decision VI/9 of the Parties to the Montreal
Protocol,
the purity of controlled substances for laboratory
purposes should be at least 99,0 % for 1,1,1 trichloroethane
and 99,5 % for CFCs and carbon tetrachloride.

The procedure allocating quantities of controlled substances for
the above essential uses foressen by Council Regulation (EC) No
3093/94 is the following:

1. Essential use applications may be made by any interested
users of metered dose inhales (MDIs) or laboratory uses.
in
Requests should contain the information as set out
Annex I of this notice for MDIs or Annex II of this notice
for laboratory uses.

2. Interested parties should send their application within one

month of publication of this notice to:

D(cid:246)rthe Ohm,
European Commission,
Directorate-General XI,
Environment, Nuclear Safety and Civil Protection,
Unit D.3,
Rue de la Loi/Wetstraat 200,
B-1049 Brussels.

Enquiries can be made in writing to the above address or by
telephone (32-2) 296 36 92 or telefax (32-2) 296 95 54.

A copy of the application should also be sent to the
competent authority of the Member State (See Annex
III).

3. Applications received within the period allowed under this
notice will be considered by the Commission in accordance
with the procedure set out in Article 16 of Regulation (ESS
3093/94 on substances that deplete the ozone layer.

4. On the basis of

the above procedure, a Commission
Decision will allocate quantities of controlled substances to
the users of those applications in the Community for 2000
for which additional production and importation of
controlled substances will be permitted.

(1) OJ L 333, 22.12.1994.

subparagraph 2

(2) Copies of

these conditions are available from the address in

22.7.1999

EN

Official Journal of the European Communities

C 208/13

5. The Commission will

then issue licences to those users
identified and shall notify them of the use for which they
have authorisation, the substance they are authorised to use
and the quantity of the controlled substances concerned.

6. Those users holding an essential use licence for a controlled
substance for 2000 will be able to present their licensed

demands to a producer or if necessary request an import
licence from the Commission for the purpose of meeting
the licensed demand. The producer may be authorised by
the competent authority of the Member State in which its
relevant production is situated to produce the controlled
The
that
substance
competent authority of the Member State shall notify the
Commission well in advance of any such authorisation.

for meeting

demand.

licensed

ANNEX I

Form to be used to declare

METERED DOSE INHALERS (MDIs) (1)

for the treatment of asthma and other chronic obstructive diseases

1. Name of the company:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Address of the company:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Contact person:

Telephone No:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Fax No:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

e-mail address:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2. Data concerning the volume requested in 2000:

Substance

Formula

CN-code

Quantity requested in
2000
(in kg)

Trichlorofluoromethane

Dichlorodifluoromethane

Trichlorotrifluoroethane

Dichlorotetrafluoroethane

Other (*)

(*) To be specified.

CFC 11

CFC 12

CFC 113

CFC 114

CFCl3

CF2Cl2

C2F3Cl3

C2F4Cl2

2903 41 00

2903 42 00

2903 43 00

2903 44 00

(1) Applications for the use of Metered Dose Inhalers (MDIs) for the treatment of asthma and other chronic obstructive diseases will need
to be accompanied by a copy of the relevant marketing authorisation issued by the competent national authorities confirming this
specific use.

C 208/14

EN

Official Journal of the European Communities

22.7.1999

Total quantity to be imported:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(in kg)

Total quantity to be obtained from producers within the EU:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(in kg)

3. Historical data:

Please indicate below the volume of the substances used in 1996, 1997 and 1998, as well as estimates for 1999.

Substance

1996

1997

1998

1999 (estimates)

(in kg)

CFC 11

CFC 12

CFC 113

CFC 114

Other (specify)

4. Name, address and telephone number of manufacturer or supplier:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

5. Please indicate below the stocks of CFCs currently held by your company

Substance

Stocks

(in kg)

CFC 11

CFC 12

CFC 113

CFC 114

Other

We hereby certify that we intend to use the declared substance for the essential use granted in the Community
in 2000, as indicated in this notice.

Place:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Date:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Name:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Signature:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

22.7.1999

EN

Official Journal of the European Communities

C 208/15

ANNEX II

Form to be used to declare

LABORATORY USES

1. Name of the company:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Address of the company:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Contact person:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Telephone No:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Fax No:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

e-mail address:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2. Data concerning the volume requested in 2000:

Substance

Formula

CN-Code

Quantity requested in
2000
(in kg)

Trichlorofluoromethane

Dichlorodifluoromethane

Trichlorotrifluoroethane

Dichlorotetrafluoroethane

Chloropentafluoroethane

Carbon Tetrachloride

1,1,1-trichloroethane

Other (1)

CFC 11

CFC 12

CFC 113

CFC 114

CFC 115

CFCl3

CF2Cl2

C2F3Cl3

C2F4Cl2

C2F5Cl

CCl4

2903 41 00

2903 42 00

2903 43 00

2903 44 00

2903 44 90

2903 14 00

C2H3Cl3

2903 19 10

(1) To be specified (name, formula, CN-code and purity).

Total quantities to be obtained from EU producers:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(in kg)

Total quantities to be imported:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(in kg)

Total quantities to be supplied from sources (other than producers) within the EU:

. . . . . . . . . . . . . . .

(in kg)

C 208/16

EN

Official Journal of the European Communities

22.7.1999

3. Please justify why the use of ozone depleting substances (ODS) is still necessary and explain the steps being taken to

identify non ODS alternatives, including the likely dates when ODS can be phased out in this use.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4. Historical data:

Please indicate below the volumes of any controlled substances used for essential laboratory and analytical uses in
1996, 1997 and 1998 as well as estimates for 1999.

Substance

1996

1997

1998

1999 estimates

(in kg)

5. Are you the end-user of the controlled substances?

NO, please go to 6.

YES, please go to 7.

6. Name, address and telephone number of the producer or importer from which the controlled substances will be

obtained:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

22.7.1999

EN

Official Journal of the European Communities

C 208/17

Names, addresses and telephone numbers of your clients (add additional annexes if needed):

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

7. Do you intend to acquire the controlled substances directly from

a producer/importer or

a supplier

or distributor?

Name, address and telephone number of producer or supplier (add additional annexes if needed):

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

8. Declaration:

We hereby certify that we intend to use the declared substances for the essential use granted in the
Community in 2000 in accordance with the conditions applicable to the exemption for laboratory and
analytical uses and the conditions indicated in this notice.

Place:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Date:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Name:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Signature:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

C 208/18

EN

Official Journal of the European Communities

22.7.1999

ALLEGATO III / ANEXO III / ANEXO III / ANNEX III / ANNEXE III / ANHANG III / BIJLAGE III / BILAG III /

BILAGA III / LIITE III / —`(cid:209)`(cid:209)(cid:212)˙(cid:204)` III

AUSTRIA

Mr Paul Krajnik
Ministry of the Environment
Chemical Department
Stubenbastei 5
A-1010 Wien

BELGIUM

Mrs Lutgarde Coppens
MinistŁre de la SantØ Publique et de l’Environnement
DØpartement de l’Environnement
19, Boulevard Pacheco (cid:151) bte 7
B-1010 Brussels

DENMARK

Mr Henri Heron
Miljłstyrelsen
Strandgade 29
DK-1401 Copenhagen K

FINLAND

Mrs Eliisa Irpola
Finnish Environment Institute
Kes(cid:228)katu 6
FIN-00121 Helsinki

FRANCE

Mrs Laurence Musset
MinistŁre de l’Environnement
DRPR/BSPC
20, Avenue de SØgur
F-75302 Paris 07 SP

GERMANY

Mr Heinrich W. Kraus
Federal Ministry for the Environment
Dept. JG 115
Bernkasteler Stra(cid:223)e 8
D-53175 Bonn

GREECE

Mrs Elpida Politis
Ministry for the Environment, Physical Planning and
Public Works
International Activities and EEC Department
17 Ameliedos Street
GR-11523 Athens

IRELAND

Ms Nuala McLoughlin
Department of the Environment
Environment International
Custom House
IRL-Dublin 1

ITALY

Mrs Giuliana Gasparrini
Ministry of Environment
Atmospheric Pollution Department
Via Ferratella in Laterano, 33
I-00184 Roma

LUXEMBOURG

Mr Theo Weber
Administration de l’Environnement
1, Rue Bender
L-1229 Luxembourg

PORTUGAL

Ms Cristina Vaz Nunes
MinistØrio do Ambiente
Instituto de Meteorologia
Rua C ao Aeroporto de Lisboa
P-1700 Lisboa

SPAIN

Mr `ngel Rasc(cid:243)n
Ministerio de Medio Ambiente
DG de Calidad y Evaluaci(cid:243)n Ambiental
Pza. San Juan de la Cruz s/n
4a Planta (cid:151) Despacho 4.60
E-28071 Madrid

SWEDEN

Ms Maria Ujfalusi
Swedish Environmental Protection Agency
Naturv(cid:229)rdsverket
Blekholmsterassen 36
S-106 48 Stockholm

NEDERLAND

Dr. Joop A. van Haasteren
Ministerie van Volkshuisvesting, Ruimtelijke Ordening
en Milieubeheer
Postbus 30945
Rijnstraat 8
2500 GX Den Haag
Nederland

UNITED KINGDOM

Mrs Maria Nolan
Department of the Environment, Transport and Regions
Global Atmosphere Division
3rd floor (cid:151) zone 3/C2
Ashdown House
123, Victoria Street
UK-SW1E 6DE London